Recursion Pharmaceuticals (RXRX) Insider Trading & Ownership $7.32 -0.03 (-0.41%) (As of 07/5/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Recursion Pharmaceuticals (NASDAQ:RXRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage15.75%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$13.57 M RXRX Insider Buying and Selling by Quarter Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… Recursion Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/27/2024Tina MarriottCOOSell6,000$7.21$43,260.00 6/25/2024Blake BorgesonDirectorSell11,447$9.51$108,860.97 6/13/2024Michael SecoraCFOSell15,000$9.32$139,800.00 6/11/2024Blake BorgesonDirectorSell11,447$8.45$96,727.15 6/5/2024Christopher GibsonCEOSell50,000$8.42$421,000.00 5/30/2024Tina MarriottCOOSell3,000$8.78$26,340.00 Urgent alert: open this for a huge profit potential (Ad)This groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.See Tim’s instructions to make this remarkably simple trade right here5/28/2024Blake BorgesonDirectorSell11,447$9.17$104,968.99 5/1/2024Christopher GibsonCEOSell50,000$7.73$386,500.00 4/30/2024Blake BorgesonDirectorSell11,447$7.95$91,003.65 4/25/2024Tina MarriottCOOSell3,000$7.67$23,010.00 4/17/2024Michael SecoraCFOSell23,124$7.58$175,279.92 4/16/2024Blake BorgesonDirectorSell11,447$7.66$87,684.02 4/3/2024Christopher GibsonCEOSell40,000$8.84$353,600.00 4/2/2024Blake BorgesonDirectorSell11,447$8.82$100,962.54 3/28/2024Christopher GibsonCEOSell40,000$10.10$404,000.00 3/21/2024Tina MarriottCOOSell8,000$10.75$86,000.00 3/19/2024Blake BorgesonDirectorSell20,054$10.79$216,382.66 3/13/2024Michael SecoraCFOSell25,000$11.03$275,750.00 3/6/2024Christopher GibsonCEOSell36,319$11.86$430,743.34 3/5/2024Blake BorgesonDirectorSell20,054$12.06$241,851.24 2/22/2024Tina MarriottCOOSell8,000$14.89$119,120.00 2/20/2024Blake BorgesonDirectorSell20,054$12.32$247,065.28 2/13/2024Michael SecoraCFOSell25,000$9.86$246,500.00 2/7/2024Christopher GibsonCEOSell48,272$9.22$445,067.84 2/6/2024Blake BorgesonDirectorSell11,447$9.30$106,457.10 1/25/2024Tina Marriott LarsonCOOSell8,000$10.35$82,800.00 1/23/2024Blake BorgesonDirectorSell20,054$10.58$212,171.32 1/16/2024Michael SecoraCFOSell25,000$10.45$261,250.00 1/16/2024Shafique ViraniInsiderSell18,000$10.93$196,740.00 1/9/2024Dean Y LiDirectorSell29,000$13.66$396,140.00 1/3/2024Christopher GibsonCEOSell30,853$9.49$292,794.97 12/26/2023Blake BorgesonDirectorSell20,054$10.63$213,174.02 12/15/2023Shafique ViraniInsiderSell18,000$9.60$172,800.00 12/14/2023Zavain DarDirectorSell20,141$9.00$181,269.00 12/12/2023Blake BorgesonDirectorSell11,447$7.40$84,707.80 12/12/2023Michael SecoraCFOSell25,000$7.39$184,750.00 12/6/2023Christopher GibsonCEOSell59,829$7.49$448,119.21 11/28/2023Blake BorgesonDirectorSell11,447$6.72$76,923.84 11/16/2023Tina Marriott LarsonCOOSell3,000$6.76$20,280.00 11/15/2023Shafique ViraniInsiderSell18,000$6.51$117,180.00 50-year Wall Street Legend Issues July Stock Warning (Ad)July is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks – including NVDA – stumbling?To see this July stock warning for yourself – 100% free – click here.11/14/2023Blake BorgesonDirectorSell8,885$6.32$56,153.20 11/14/2023Michael SecoraCFOSell25,000$6.32$158,000.00 11/1/2023Christopher GibsonCEOSell37,177$5.20$193,320.40 10/31/2023Blake BorgesonDirectorSell8,885$5.27$46,823.95 10/26/2023Tina Marriott LarsonCOOSell3,000$5.63$16,890.00 10/17/2023Blake BorgesonDirectorSell8,885$6.58$58,463.30 10/16/2023Shafique ViraniInsiderSell18,000$6.30$113,400.00 10/10/2023Michael SecoraCFOSell25,000$7.07$176,750.00 10/4/2023Christopher GibsonCEOSell59,794$7.21$431,114.74 10/3/2023Blake BorgesonDirectorSell8,885$7.29$64,771.65 9/28/2023Tina Marriott LarsonCOOSell3,000$7.72$23,160.00 9/19/2023Blake BorgesonDirectorSell8,885$8.36$74,278.60 9/15/2023Shafique ViraniInsiderSell18,000$8.66$155,880.00 9/13/2023Michael SecoraCFOSell25,000$8.69$217,250.00 9/6/2023Christopher GibsonCEOSell33,765$8.78$296,456.70 9/5/2023Blake BorgesonDirectorSell8,885$8.79$78,099.15 8/24/2023Tina Marriott LarsonCOOSell3,000$8.66$25,980.00 8/22/2023Blake BorgesonDirectorSell8,885$8.91$79,165.35 8/16/2023Michael SecoraCFOSell25,000$8.90$222,500.00 8/15/2023Shafique ViraniInsiderSell18,000$9.25$166,500.00 8/8/2023Blake BorgesonDirectorSell17,770$11.16$198,313.20 8/2/2023Christopher GibsonCEOSell65,015$13.04$847,795.60 7/27/2023Tina Marriott LarsonCOOSell8,000$13.62$108,960.00 7/26/2023Shafique ViraniInsiderSell20,000$14.41$288,200.00 7/25/2023Blake BorgesonDirectorSell18,719$14.61$273,484.59 7/18/2023Michael SecoraCFOSell25,000$13.63$340,750.00 7/17/2023Shafique ViraniInsiderSell30,000$11.72$351,600.00 7/13/2023Terry-Ann BurrellDirectorSell8,275$12.59$104,182.25 7/12/2023Christopher GibsonCEOSell31,818$13.14$418,088.52 7/11/2023Blake BorgesonDirectorSell8,885$6.89$61,217.65 (Data available from 1/1/2013 forward) RXRX Insider Trading Activity - Frequently Asked Questions Who is on Recursion Pharmaceuticals's Insider Roster? The list of insiders at Recursion Pharmaceuticals includes Blake Borgeson, Christopher Gibson, Dean Y Li, Michael Secora, Mubadala Investment Co Pjsc, Shafique Virani, Terry-Ann Burrell, Tina Marriott, Tina Marriott Larson, and Zavain Dar. Learn more on insiders at RXRX. What percentage of Recursion Pharmaceuticals stock is owned by insiders? 15.75% of Recursion Pharmaceuticals stock is owned by insiders. Learn more on RXRX's insider holdings. Which Recursion Pharmaceuticals insiders have been buying company stock? The following insider purchased RXRX shares in the last 24 months: Mubadala Investment Co Pjsc ($4,440,853.30). How much insider buying is happening at Recursion Pharmaceuticals? Insiders have purchased a total of 581,017 RXRX shares in the last 24 months for a total of $4,440,853.30 bought. Which Recursion Pharmaceuticals insiders have been selling company stock? The following insiders have sold RXRX shares in the last 24 months: Blake Borgeson ($4,285,747.52), Christopher Gibson ($8,784,066.26), Dean Y Li ($396,140.00), Michael Secora ($2,646,829.92), Shafique Virani ($2,763,458.38), Terry-Ann Burrell ($104,182.25), Tina Marriott ($297,730.00), Tina Marriott Larson ($1,237,390.00), and Zavain Dar ($181,269.00). How much insider selling is happening at Recursion Pharmaceuticals? Insiders have sold a total of 2,211,996 Recursion Pharmaceuticals shares in the last 24 months for a total of $20,696,813.33 sold. More Insider Trading Tools from MarketBeat Related Companies: PTC Therapeutics Insider Buying Arcus Biosciences Insider Buying Schrödinger Insider Buying AbCellera Biologics Insider Buying Emergent BioSolutions Insider Buying Absci Insider Buying Vaxcyte Insider Buying Repligen Insider Buying Exelixis Insider Buying Halozyme Therapeutics Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, TreaceIs CAVA Overextended? A Closer Look at This High-Flying StockOccidental Petroleum: Buffett Causes OXY Stock Rebound3 Tech Stocks Insiders, Major Shareholders, and Institutions BuyThe Top 3 Stocks Sold by Insiders This Quarter This page (NASDAQ:RXRX) was last updated on 7/6/2024 by MarketBeat.com Staff From Our PartnersWhy Conservative Americans Are Turning to Gold in 2024Welcome to the financial rollercoaster of 2024, where inflation is relentless, stock markets are inflated, and...All American Assets | Sponsored50-year Wall Street Legend Issues July Stock WarningJuly is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | SponsoredBiden to drop out; finish out his term?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBill Gates is all about this tiny $2 stockWhat does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthles...Timothy Sykes | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | Sponsored"The Biggest Drug Ever" Is ComingUBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Phar...Behind the Markets | SponsoredGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Recursion Pharmaceuticals, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Recursion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.